-
Forward Look
Truth in AdvertisingSeveral countries explore legality of requiring cigarettes to carry graphic pictures and health warnings.
by Sue Rochman
-
More Than a SignatureThe informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
-
Forward Look
Coming Up ShortA limited supply of cancer medications is affecting care.
by Steve McIver
-
Survivor Profile
Betting on ScienceDiagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.
by Betty Russell
-
Get Involved
Sending Get Well WishesJoan A. Smith organizes volunteers' efforts to send cards to cancer patients.
by Maria Wolf
-
Editor's Letter
Making PlansA cancer diagnosis can quickly change your “other plans.”
by Kevin McLaughlin
-
Forward Look
When the Cancer Doctor Gets CancerQ & A with breast surgeon Susan Love on her new role: cancer survivor.
by Betty Russell
-
Forward Look
Paying a Steep PriceNew laws are pushing health insurers to make oral cancer drugs affordable.
by Betty Russell
-
Forward Look
This Way to the Quit LineDoctors and researchers are encouraged to talk to patients about tobacco use.
by Sue Rochman
-
Forward Look
Rally for Medical Research“More progress, more hope, more life.” Photo © AACR / Vera LaMarche 2013 That was the rallying cry of the thousands of researchers, patient advocates and cancer survivors who attended the Rally for Medical Research, held April 8 in Washington, D.C. Their goal was to draw attention to the devastating impact that across-the-board federal spending […]
by Marci A. Landsmann
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
